Eli Lilly and Company (Lilly) has revealed plans to open a new research facility for genetic medicine dubbed as Lilly Institute for Genetic Medicine in Boston with an investment of around $700 million. According to the US pharma giant, the investment in the Boston Seaport site is part of its strategy to advance RNA based […]
Eli Lilly and Company (Lilly) has signed a deal worth at least $720 million with the US government to deliver up to 600,000 doses of bebtelovimab, its investigational drug for Covid-19. According to Lilly, the US government will accept the doses of bebtelovimab if it secures an emergency use authorization (EUA) from the US Food […]
Eli Lilly and Company (Lilly) has secured Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for bebtelovimab for the treatment of mild-to-moderate Covid-19. According to Lilly, bebtelovimab is a neutralizing IgG1 monoclonal antibody (mAb) directed against the spike protein of SARS-CoV-2, which has also shown capability to neutralize against the Omicron […]
Arkuda Therapeutics, a US-based biotechnology company, has raised $64 million in Series B financing. The new funding will help Arkuda Therapeutics boost the production of medicines that treat neurodegenerative diseases caused by the biological dysfunction of progranulin, a protein known to play a key role in lysosomal function and innate immunity in the brain. Arkuda […]
Eli Lilly and Company (Lilly) said that it will invest more than $1 billion to build a new manufacturing plant in Concord, North Carolina. The new facility will be engaged in manufacturing parenteral (injectable) products and devices and boost the manufacturing capacity of the US pharma giant. It will generate close to 600 new jobs […]
Cipla has signed a licensing deal with the Indian subsidiary of US pharma giant Eli Lilly and Company (Lilly) pertaining to the latter’s diabetes treatments — Humalog [Insulin Lispro I.P. (rDNA Origin) injection] and Trulicity (Dulaglutide) in India. In this connection, Lilly will transfer its rights in India to sell, promote, and distribute the two […]
Eli Lilly and Company (Lilly) has taken full ownership of California-based biotech company Protomer Technologies in a deal that is potentially worth more than $1 billion based on achieving future development and commercial milestones. Protomer Technologies has developed a peptide- and protein-engineering platform for identifying and synthesizing molecules that can sense glucose or other endogenous […]
Cadila Healthcare (also known as Zydus Cadila) said that it has secured tentative approval from the US Food and Drug Administration (FDA) for marketing Pemetrexed for Injection in 100mg/vial, 500mg/vial, and 1000mg/vial, single-dose vials. Pemetrexed for Injection is the generic for Eli Lilly and Company (Lilly) owned Pemetrexed, which is sold under Alimta and other […]
Natco Pharma has signed a royalty-free, non-exclusive, voluntary licensing agreement with Eli Lilly and Company (Lilly) for manufacturing and commercializing Baricitinib for the treatment of Covid-19 in India. With the licensing agreement signed, Natco has withdrawn the application it had filed with the Indian Patent Office, under which had sought compulsory license against Lilly for […]
Torrent Pharmaceuticals (Torrent Pharma) has signed a licensing agreement with Eli Lilly and Company with an objective to bring the latter’s baricitinib for Covid-19 treatment in India. The royalty free, non-exclusive voluntary agreement enables Torrent Pharma to manufacture and distribute baricitinib along with Lilly’s other license partners. According to Torrent Pharma, the agreement will help […]